Other Industry Events

CIRM / REGENERATIVE MEDICINE CONSORTIUM (rmc) PRESENT:
CELL THERAPIES FOR PARKINSON’S DISEASE FROM DISCOVERY TO CLINIC

MODERATOR:

• Ellen Feigal, MD, Senior Vice President of Research and Development, CIRM

EXPERT SPEAKERS:

• Wilson Bryan, M.D., Director, Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)
• Jeffrey Kordower, Ph.D., Professor of Neurological Sciences and Neurology, Rush University Medical Center
• Karl Johe, Ph.D., Chief Scientific Officer, Neuralstem

TOPICS TO BE COVERED:

The focus of this webinar is on Parkinson’s Disease – using the Lessons Learned to overcome the challenges as cell based therapies move from discovery to the clinic.

• Presentation by FDA – Considerations for first-in-human clinical trials of cell therapies for Parkinson’s Disease
• Lessons learned from human fetal transplants and from gene therapy
• State of preclinical research with hESCs and hiPSC cell therapies
• Questions and Answers

RESOURCES:

• CIRM Parkinson’s Disease Workshop White Paper Report [pdf]

To test your system setup in advance of the November 14 webinar, please go to the Webex test website (click here)
The website will simulate joining a Webex meeting and test if you are missing any software, etc.  If you have any technical issues with Webex, please call Webex support at 866.229.3239.

FOR FULL EVENT INFORMATION VISIT: http://www.cirm.ca.gov/agendas/10182013/webinar-cell-therapies-parkinson%E2%80%99s-disease-discovery-clinic